MicroStrategy
MSTR
Adobe
ADBE
Salesforce
CRM
Apple
AAPL
Meritage Homes
MTH
US Stock MarketDetailed Quotes
DNTH Dianthus Therapeutics
- 23.800
- +0.760+3.30%
Close Dec 20 16:00 ET
- 23.800
- 0.0000.00%
Post 16:20 ET
704.41MMarket Cap-10.42P/E (TTM)
24.215High22.350Low389.93KVolume22.790Open23.040Pre Close9.20MTurnover3.13%Turnover RatioLossP/E (Static)29.60MShares33.77052wk High2.08P/B296.82MFloat Cap10.02052wk Low--Dividend TTM12.47MShs Float336.000Historical High--Div YieldTTM8.10%Amplitude5.136Historical Low23.602Avg Price1Lot Size
Dianthus Therapeutics Key Stats
Quarterly+Annual
YOY
| (Q3)Sep 30, 2024 | (Q2)Jun 30, 2024 | (Q1)Mar 31, 2024 | (FY)Dec 31, 2023 | (Q4)Dec 31, 2023 | (Q3)Sep 30, 2023 | (Q2)Jun 30, 2023 | (Q1)Mar 31, 2023 | (FY)Dec 31, 2022 | (Q4)Dec 31, 2022 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Operating Cash Flow (Indirect Method) | ||||||||||
| Cash flow from continuing operating activities | -112.84%-21.27M | -207.08%-14.53M | -45.28%-14.94M | -26.80%-36.86M | -33.93%-11.85M | -9.99M | -4.73M | -10.28M | -193.52%-29.07M | -8.85M |
| Net income from continuing operations | -70.52%-25.17M | -58.05%-17.61M | -93.93%-13.75M | -52.95%-43.56M | -4.42%-10.56M | ---14.76M | ---11.14M | ---7.09M | -117.22%-28.48M | ---10.12M |
| Depreciation and amortization | 33.33%116K | 32.14%111K | 32.10%107K | 141.50%355K | 110.20%103K | --87K | --84K | --81K | --147K | --49K |
| Change In working capital | -32.23%2.6M | -95.24%289K | 18.37%-2.82M | 394.13%4.86M | -244.16%-1.59M | --3.84M | --6.07M | ---3.45M | -152.61%-1.65M | --1.11M |
| -Change in receivables | -3,575.86%-1.01M | -121.64%-799K | -134.13%-398K | 223.98%5.16M | 123.70%273K | --29K | --3.69M | --1.17M | -181.98%-4.16M | ---1.15M |
| -Change in prepaid assets | -120.00%-378K | -153.89%-291K | 107.76%241K | 119.49%123K | -1,148.92%-2.42M | --1.89M | --540K | --116K | -132.84%-631K | --231K |
| -Change in payables and accrued expense | 631.05%5.65M | 7.70%3.25M | 36.86%-2.99M | -71.01%661K | -21.07%1.6M | --773K | --3.01M | ---4.73M | -53.65%2.28M | --2.03M |
| -Change in other current assets | -81,100.00%-1.62M | -26,242.86%-1.83M | 6,760.00%343K | -3,212.90%-1.03M | -5,861.11%-1.04M | ---2K | --7K | --5K | -3.33%-31K | --18K |
| -Change in other working capital | -103.67%-42K | 96.87%-37K | -88.89%-17K | -106.17%-55K | 60.87%-9K | --1.15M | ---1.18M | ---9K | --891K | ---23K |
| Cash from discontinued investing activities | ||||||||||
| Operating cash flow | -112.84%-21.27M | -207.08%-14.53M | -45.28%-14.94M | -26.80%-36.86M | -33.93%-11.85M | ---9.99M | ---4.73M | ---10.28M | -193.52%-29.07M | ---8.85M |
| Investing cash flow | ||||||||||
| Cash flow from continuing investing activities | -2,154.36%-259.36M | -94.65%1.17M | -130.37%-5.51M | 133.86%20.25M | 34.96%-8.24M | -11.51M | 21.86M | 18.13M | -181,169.70%-59.82M | -12.67M |
| Capital expenditure reported | 61.54%-25K | 19.05%-17K | -128.57%-32K | 20.86%-110K | 65.52%-10K | ---65K | ---21K | ---14K | -321.21%-139K | ---29K |
| Net investment purchase and sale | -2,166.95%-259.34M | -94.58%1.19M | -130.17%-5.48M | 134.12%20.36M | 34.89%-8.23M | ---11.44M | --21.89M | --18.15M | ---59.68M | ---12.64M |
| Cash from discontinued investing activities | ||||||||||
| Investing cash flow | -2,154.36%-259.36M | -94.65%1.17M | -130.37%-5.51M | 133.86%20.25M | 34.96%-8.24M | ---11.51M | --21.86M | --18.13M | -181,169.70%-59.82M | ---12.67M |
| Financing cash flow | ||||||||||
| Cash flow from continuing financing activities | -99.79%296K | -2.2M | 217.85M | 38.17%133.57M | -4.87M | 138.44M | 0 | 0 | 548.31%96.68M | 0 |
| Net issuance payments of debt | --0 | --0 | --0 | --0 | --0 | --0 | --0 | --0 | --0 | --0 |
| Net common stock issuance | --0 | --0 | --230M | --72M | --0 | --72M | --0 | --0 | --0 | --0 |
| Net preferred stock issuance | ---- | ---- | ---- | --0 | ---- | ---- | ---- | ---- | 566.67%100M | --0 |
| Proceeds from stock option exercised by employees | 5,820.00%296K | --47K | --271K | --5K | --0 | --5K | --0 | --0 | --0 | --0 |
| Net other financing activities | --0 | ---2.24M | ---12.42M | 1,952.26%61.57M | ---4.87M | ---- | ---- | ---- | -3,677.27%-3.32M | --0 |
| Cash from discontinued financing activities | ||||||||||
| Financing cash flow | -99.79%296K | ---2.2M | --217.85M | 38.17%133.57M | ---4.87M | --138.44M | --0 | --0 | 548.31%96.68M | --0 |
| Net cash flow | ||||||||||
| Beginning cash position | 677.71%314.24M | 1,317.11%329.79M | 758.29%132.39M | 101.95%15.43M | 325.94%157.35M | --40.41M | --23.27M | --15.43M | 186.82%7.64M | --36.94M |
| Current changes in cash | -339.72%-280.34M | -190.79%-15.56M | 2,415.60%197.4M | 1,402.07%116.97M | -15.99%-24.96M | --116.94M | --17.13M | --7.85M | 56.52%7.79M | ---21.52M |
| End cash Position | -78.46%33.9M | 677.71%314.24M | 1,317.11%329.79M | 758.29%132.39M | 758.29%132.39M | --157.35M | --40.41M | --23.27M | 101.95%15.43M | --15.43M |
| Free cash flow | -111.71%-21.29M | -206.08%-14.55M | -45.40%-14.97M | -26.57%-36.97M | -33.60%-11.86M | ---10.06M | ---4.75M | ---10.3M | -193.94%-29.21M | ---8.88M |
| Currency Unit | USD | USD | USD | USD | USD | USD | USD | USD | USD | USD |
| Audit Opinions | -- | -- | -- | Unqualified Opinion | -- | -- | -- | -- | -- | -- |
Trending US Stocks
Fed Rate Cut Beneficiaries Fed Rate Cut Beneficiaries
Stocks that are expected to benefit from a Federal Reserve rate cut. Information is provided by Futu and is a non-exhaustive list of all thematic stocks for reference purposes only.
This section presents the top 5 stocks in Fed Rate Cut Beneficiaries, ranked from highest to lowest based on real-time market data. Stocks that are expected to benefit from a Federal Reserve rate cut. Information is provided by Futu and is a non-exhaustive list of all thematic stocks for reference purposes only.
This section presents the top 5 stocks in Fed Rate Cut Beneficiaries, ranked from highest to lowest based on real-time market data.